| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/15/1992 | US5147643 DNA sequences encoding human t-PA substituted at position 275 or at positions 275 and 277 and pharmaceutical compositions |
| 09/15/1992 | US5147641 Microcapsule for the removal of specific amino acids through the entero-portal recirculation |
| 09/15/1992 | US5147638 Tumor necrosis factor, antibodies, cytokines |
| 09/15/1992 | US5147637 Administering an anti-infective agent and a monoclonal antibody to reduce inflammation caused by meningitis or encephalitis |
| 09/15/1992 | US5147294 Therapeutic method for reducing chronic pain in a living subject |
| 09/15/1992 | CA2105877A1 Tgf-.beta.1/.beta.2: novel chimeric transforming growth factor-beta |
| 09/15/1992 | CA2078010A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated |
| 09/15/1992 | CA1307622C Renin-inhibiting di- and tripeptides, a process for their preparation, agents containing them, and their use |
| 09/15/1992 | CA1307483C Process for producing protein a and composition thereof |
| 09/15/1992 | CA1307478C Methods and compositions for the identification of metastatic human tumors |
| 09/15/1992 | CA1307466C Inhibition of protein kinase c by long-chain bases |
| 09/14/1992 | CA2062920A1 Compositions containing a special combination of carbohydrates to be utilized in dietetics and therapeutics, and their applications |
| 09/13/1992 | WO1992016646A1 Anti-idiotype antibodies to human melanoma-associated proteoglycan antigen |
| 09/13/1992 | WO1992016622A1 Cd2-binding domain of lymphocyte function associated antigen 3 |
| 09/13/1992 | CA2105477A1 Anti-idiotype antibodies to human melanoma-associated proteoglycan antigen |
| 09/13/1992 | CA2062659A1 Composition for sustained-release of erythropoietin |
| 09/12/1992 | WO1992016612A2 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/12/1992 | CA2105997A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/09/1992 | WO1992015331A1 Lyophilized monoclonal antibody preparation |
| 09/09/1992 | WO1992015321A1 Endothelin antagonists |
| 09/09/1992 | EP0502812A1 Recombinant antibodies specific for a growth factor receptor |
| 09/09/1992 | EP0502719A1 Plant polypeptides with inhibitory activity towards pathogenic microorganisms |
| 09/09/1992 | EP0502718A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/09/1992 | EP0502599A1 Use of IL-4 to enhance the reparitive phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals |
| 09/09/1992 | EP0502554A2 Composition comprising an oxygen radical scavenger and a surfaceactive copolymer |
| 09/09/1992 | EP0502536A1 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 09/09/1992 | EP0502474A2 Curculin B and DNA encoding same, and process for production thereof |
| 09/09/1992 | EP0502416A1 Stimulation of growth with anti-idiotypic antibodies raised against an antibody to a growth potentiating polypeptide |
| 09/09/1992 | EP0502313A2 Method for insuring adequate intracellular glutathione in tissue |
| 09/09/1992 | EP0502198A1 Novel polypeptide and anti-hiv drug prepared therefrom |
| 09/09/1992 | EP0502188A1 Cloned glutamic acid decarboxylase |
| 09/09/1992 | EP0502171A1 Composition for inducing granulocyte production or b cell production in peripheral blood |
| 09/09/1992 | EP0502160A1 Aids therapy and vaccine |
| 09/09/1992 | EP0502146A1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEIN gE |
| 09/09/1992 | EP0502131A1 Production of multimeric glycoproteins through chemical coupling |
| 09/09/1992 | EP0502124A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 09/09/1992 | EP0502113A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute |
| 09/09/1992 | EP0502080A1 Anti-inflammatory compositions and methods |
| 09/09/1992 | EP0502075A1 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
| 09/09/1992 | EP0502007A1 Arginine nicotinate for reducing blood cholesterol |
| 09/09/1992 | EP0473716A4 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 09/09/1992 | EP0382720B1 Diagnosing obesity caused by a genetic abnormality and method of therapeutically treating genetically caused obesity |
| 09/09/1992 | EP0316322B1 Tetrapeptide inhibiting the proliferation cycle of haematopoietic strain cells, methods of production and applications thereof |
| 09/09/1992 | EP0305400B1 A composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine |
| 09/09/1992 | EP0292517B1 Improvements in or relating to the use of epidermal growth factor |
| 09/09/1992 | EP0274532B1 Wound-healing drug and cosmetics |
| 09/09/1992 | EP0227818B1 Antiglaucoma compositions |
| 09/09/1992 | EP0214281B1 Protein absorption enhancing agents |
| 09/09/1992 | EP0180595B1 Method of inhibiting and inducing human platelet aggregation |
| 09/09/1992 | CN1064313A Realignment protein of human digestive enzyme and process for their preparation |
| 09/09/1992 | CN1064217A Pneumococcal polysaccharide conjugate vaccine |
| 09/09/1992 | CA2104860A1 Endothelin antagonists |
| 09/09/1992 | CA2082169A1 Freeze-dried preparation containing monoclonal antibody |
| 09/09/1992 | CA2062388A1 Method and preparation for the inhibition or prevention of cancer metastasis |
| 09/09/1992 | CA2062376A1 Medicinal composition |
| 09/09/1992 | CA2061891A1 Flunarizine containing anti-neoplastic compositions |
| 09/08/1992 | US5145951 Protected ologopeptides; treating aids |
| 09/08/1992 | US5145872 Enzyme inhibitors, analgesics |
| 09/08/1992 | US5145838 Peptide derivatives |
| 09/08/1992 | US5145837 Administering somatostatin derivative |
| 09/08/1992 | US5145681 Compositions containing protease produced by vibrio and method of use in debridement and wound healing |
| 09/08/1992 | US5145680 Vitronectin solution |
| 09/08/1992 | US5145679 Topical emollient for prevention and treatment of circulatory induced lesions |
| 09/08/1992 | US5145677 Process for treatment of diseases |
| 09/08/1992 | US5145676 Method and agents for promoting wound healing |
| 09/08/1992 | CA2037727A1 Removing lps pyrogen from aqueous solution |
| 09/08/1992 | CA1307374C Peptides containing an aliphatic-aromatic ketone side chain |
| 09/08/1992 | CA1307373C Process for the isolation and preparation of a pasteurized alpha_-antiplasmin product |
| 09/08/1992 | CA1307289C2 Peptidylaminodiols |
| 09/08/1992 | CA1307221C Brain-derived growth factor |
| 09/08/1992 | CA1307218C Onco-fetal specific monoclonal antibodies methods of preparation and use |
| 09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
| 09/07/1992 | WO1992015681A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
| 09/07/1992 | CA2105572A1 Human galanin, cdna clones encoding human galanin and a method of producing human galanin |
| 09/06/1992 | WO1992015610A1 Hirudin analogue or salt thereof, production thereof, and anticoagulant containing the same as active ingredient |
| 09/06/1992 | CA2081305A1 Hirudin variants or their salts, method for their production and anticoagulants having said compounds as active ingredients |
| 09/05/1992 | CA2062174A1 Curculin b and dna encoding same, and process for production thereof |
| 09/05/1992 | CA2061862A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/05/1992 | CA2061861A1 Plant polypeptides with inhibitory activity towards pathogenic microorganisms |
| 09/03/1992 | WO1992014837A1 Intestinal trefoil proteins |
| 09/03/1992 | WO1992014834A1 Insulin-like growth factor binding protein |
| 09/03/1992 | WO1992014832A1 Processes for purifying human bcdf |
| 09/03/1992 | WO1992014757A1 Endothelial cell-monocyte adhesion molecule |
| 09/03/1992 | WO1992014754A1 Process for the phosphorylation of insulin and product produced thereby |
| 09/03/1992 | WO1992014752A1 Primitive cell colony stimulating factors vectors, antibodies, and methods of use |
| 09/03/1992 | WO1992014751A1 Peptides for treatment |
| 09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | WO1992014749A1 Thyroid-derived chondrocyte-stimulating factor |
| 09/03/1992 | WO1992014704A1 2-substituted-2-imidazolines |
| 09/03/1992 | WO1992014490A1 Composition and method for immunostimulation in mammals |
| 09/03/1992 | WO1992014485A1 A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 09/03/1992 | WO1992014484A1 Methods and compositions for the treatment of infection and control of flora |
| 09/03/1992 | WO1992014481A1 Method and compositions for inducing bone growth |
| 09/03/1992 | WO1992014479A1 Composition for rectal administration of difficultly absorbable peptide |
| 09/03/1992 | WO1992014467A1 Therapeutic agents for the treatment of multidrug resistance to cancers |
| 09/03/1992 | WO1992014449A1 Controlled release microparticulate delivery system for proteins |
| 09/03/1992 | WO1992014448A1 Binding of growth hormone to liposomes |
| 09/03/1992 | WO1992011850A3 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| 09/03/1992 | DE4125251C1 Drug containing a bovine protein homologous to human MCP-1 - for treating inflammation, tumours, thrombosis, and immune reactions, also for diagnosis |
| 09/03/1992 | DE4106570A1 Neue inhibitoren der endothelzell-proliferation New inhibitors of endothelial cell proliferation- |